Introduction {#s1}
============

The [a]{.ul}mino acid-[p]{.ul}olyamine-organo[c]{.ul}ation (APC) superfamily of secondary transporters encompasses a broad range of evolutionarily-related proteins that transport diverse substrates including neurotransmitters, metabolites, and transition metals in organisms throughout the tree of life ([@bib63]; [@bib65]). In humans alone, the APC superfamily encompasses 11 subfamilies of distinct solute carrier proteins ([@bib46]). These transporters harness the energy stored in preexisting transmembrane ion gradients. The LeuT fold ([@bib67]) is the core structural unit that undergoes conformational rearrangements necessary for alternating access-based transport in the APC superfamily. This fold consists of ten transmembrane (TM) segments, divided into two pseudosymmetric, interlocking five-TM repeats, although many members have additional TMs. Primary substrates bind in a pocket formed by non-helical regions of TM1 and TM6, close to the center of the membrane. Co-transported coupling ions---typically Na^+^ and/or H^+^---bind at the interface between two proposed domains ([@bib45]; [@bib50]): a 'bundle' formed by TMs 1, 2, 6, and 7; and a 'scaffold' or 'hash' domain comprising most or all of the remaining six TMs ([@bib24]). When all substrates are bound, conformational rearrangement closes an external vestibule between 'bundle' and 'scaffold' and opens an intracellular vestibule between the two domains to allow substrate release ([@bib7]; [@bib23]; [@bib52]). Despite the common fold, many APC members have little-to-no sequence identity, consistent with mechanistic divergences, including variance in the identity and stoichiometry of the coupled ions ([@bib35]; [@bib51]) and in which helices move the most to open and close the inner and outer gates ([@bib32]; [@bib30]; [@bib31]; [@bib33]; [@bib37]; [@bib48]; [@bib55]; [@bib64]).

[N]{.ul}atural [r]{.ul}esistance-[a]{.ul}ssociated [m]{.ul}acrophage [p]{.ul}roteins (Nramps) are APC-superfamily transition metal transporters that enable uptake of rare micronutrients such as Mn^2+^ in plants and bacteria and Fe^2+^ in animals ([@bib11]; [@bib15]; [@bib43]). Nramps bind and/or transport biologically-essential divalent metals such as Mn^2+^, Fe^2+^, Co^2+^, Ni^2+^, Cu^2+^, Zn^2+^---and toxic metals like Cd^2+^, Pb^2+^, and Hg^2+^---but not the abundant alkaline earth metals Mg^2+^ and Ca^2+^ ([@bib8]; [@bib18]). Metal uptake by Nramps is typically stimulated by acidic pH and accompanied by proton influx ([@bib13]; [@bib19]; [@bib27]). However, many homologs also display considerable proton uniport---proton transport in the absence of added metal that suggests loose, if any, coupling between the two substrates ([@bib13]; [@bib27]; [@bib36]; [@bib42]; [@bib66]). To date no studies have conclusively demonstrated that Nramp is in fact a thermodynamically coupled secondary transporter capable of harnessing a favorable gradient of metal or proton to power electrochemically-uphill transport of the other substrate.

Nramps have 11 or 12 TMs, the first ten forming a LeuT fold, as seen in structures of three bacterial Nramp homologs ([@bib9]; [@bib18]; [@bib19]), including our model system *Deinococcus radiodurans* (Dra)Nramp ([@bib9]). Conserved aspartate, asparagine, and methionine residues in TM1 and TM6 coordinate transition metal substrates as observed in an inward-open state ([@bib18]), while only a metal-free outward-open state has been reported ([@bib19]).

Here, we provide the first complementary structures of the same Nramp homolog in multiple conformations, including the first metal-bound outward-open Nramp structure, and a novel inward-occluded structure. These allow us to fully illustrate the transport cycle for DraNramp. We also show that metal transport requires the expected alternating access bulk conformational change, whereas proton transport can occur via a more channel-like mechanism in the outward-open state. Using the structures and accompanying biochemical data, we delineate separate conserved transport pathways for metal and proton substrates and provide a mechanistic model encompassing substrate binding, release, and the conformational change process. We demonstrate novel modes of conformational rearrangement and ion shuttling in DraNramp compared to other LeuT-fold transporters, thus expanding the known repertoire of intramolecular dynamics and substrate transport mechanisms possible within this important protein family.

Results {#s2}
=======

Rational design and validation of conformationally-locked DraNramp constructs {#s2-1}
-----------------------------------------------------------------------------

A previously determined structure of a Fab-bound DraNramp in an inward-open conformation revealed the intracellular metal permeation pathway, or vestibule, between TMs 1a, 2, 5, 6b, 7, and 8 ([@bib9]). This structure was stabilized in an inward-open state by patches of mutations to intracellular loops 4--5, 6--7, and 10--11, and we thus refer to it as the Patch mutant. To observe additional conformational states of a transport cycle in a single Nramp homolog at high resolution, we developed two complementary conformationally-locked constructs for crystallization. Adding steric bulk along TM1a---for example a G45R mutation, which mimics a human anemia-causing mutation of a conserved glycine ([@bib5])---prevented the opening of the extracellular vestibule and eliminated metal transport, emphasizing the importance of the alternating-access mechanism to DraNramp function ([@bib9]). Based on these findings we pursued the G45R mutant as a new inward-locked crystallization construct.

To develop a complementary outward-locked DraNramp construct, we adapted an approach previously described for the lactose transporter LacY ([@bib34]; [@bib56]). By mapping extensive cysteine accessibility data onto the inward-open structure, we identified the external vestibule between TMs 1b, 6a, 3, 8, and 10 ([@bib9]). We created a panel of 11 tryptophan point mutants lining this predicted external vestibule ([Figure 1A](#fig1){ref-type="fig"}) to destabilize the inward-open state. An outward-locking mutation should severely impair metal transport, and indeed several mutants had impaired in vivo Co^2+^ uptake when expressed in *Escherichia coli* ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). We chose to pursue G223W---on TM6a one helical turn above the unwound metal-binding region---which like G45R eliminated Co^2+^ and Fe^2+^ metal transport ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Importantly, a tryptophan modeled in the inward-open DraNramp Patch mutant structure at position 223 clashes with the top of TM10. In contrast, in the recent outward-open structure of *Eremococcus coleocola* (Eco)Nramp (33% identity with DraNramp) the analogous glycine lines a wide aqueous channel with adequate room for tryptophan's bulk ([@bib19]).

![Design and validation of complementary conformationally-locked crystallization constructs.\
(**A**) Panel of 11 designed tryptophan mutants (pink, purple, and gray spheres; see (**B**)) and G45R disease-mutant mimic (green) mapped onto our initial inward-open DraNramp structure and color-coded by their effect on transport activity in (**B**). Single-cysteine reporters A53C (cyan) and A61C (gray) are indicated. TMs 1, 5, 6, and 10 are colored gold, TMs 3, 4, 8, and 9 blue, and TMs 2, 7, and 11 gray. \* marks the approximate location of the metal-binding site. (**B**) Relative in vivo Co^2+^ uptake rates for tryptophan mutant panel. Mutants colored gray, pink and purple did not affect, moderately decreased, or eliminated uptake, respectively. (**C**) Two complementary single-cysteine reporters enable assessment of the mutants' conformational state preferences. For simplicity, in schematics DraNramp is depicted as two gold and blue domains that reorient to accomplish alternating access. (**D**) G45R prevented modification of the A61C outward-reporter, and (**E**) G223W fully protected the A53C inward-reporter, indicating that complementary conformational locking was achieved. Both reporters fully labeled for the WT-like protein, likely because it cycles between both conformations during the assay. Data in B, D, and E are averages ± S.E.M. (n = 4). See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.](elife-41124-fig1){#fig1}

To further validate this G223W construct, we measured bulk solvent accessibility of two single-cysteine reporters: A61C on TM1b, which is exposed only in DraNramp's outward-open state ([@bib9]); and A53C on TM1a just below the metal-binding D56, a putative inward-open reporter based on comparing the Patch mutant and EcoNramp structures ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). WT-like DraNramp (with the indicated reporter cysteine and a C382S mutation to remove the lone endogenous cysteine) maintains a dynamic conformational equilibrium---even in the absence of added metal substrate---such that either reporter can be fully modified by the thiol-specific N-ethylmaleimide (NEM) at high concentrations ([Figure 1D--E](#fig1){ref-type="fig"}). G45R slightly increased A53C accessibility but fully protected A61C, indicating an outward-closed state that we will refer to as inward-locked based on these data and the structure described below. In contrast, G223W significantly increased A61C accessibility while fully protecting A53C, consistent with an outward-locked state ([Figure 1D--E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). We have thus identified two complementary constructs that trap DraNramp in outward-locked (G223W) and inward-locked (G45R) states ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Using lipidic cubic phase (LCP) to mimic the hydrophobic membrane environment, we crystallized and determined the structures of G45R and G223W to resolutions of 3.0 and 2.4 Å, respectively, both significantly improved from our earlier DraNramp structure (3.94 Å) ([Table 1](#table1){ref-type="table"} and [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}--[2](#fig2s2){ref-type="fig"}). The new high-resolution structures also allowed us to re-refine our original structure, including correction of a sequence registry error in TM11.
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###### DraNramp data collection and refinement statistics.

  ------------------------------------------------------------------------------------------------------------------------------------
                         Inward-open apo\           Inward-occluded apo\       Outward-open Mn^2+^-bound\   Outward-open apo\
                         (Patch mutant + Fab)       (G45R)                     (G223W ∆N34)                 (G223W ∆N34)
  ---------------------- -------------------------- -------------------------- ---------------------------- --------------------------
  **Data Collection**                                                                                       

  Wavelength (Å)         1.139                      0.9793                     0.9792                       0.9792

  Resolution range (Å)   46.47--3.94 (4.08--3.94)   50.00--3.00 (3.05--3.00)   39.19--2.40 (2.49--2.40)     38.14--2.36 (2.44--2.36)

  Space group            I222                       P2~1~2~1~2~1~              C121                         C121

  Unit cell (a, b, c)    113.13, 132.08, 221.0      70.73, 97.85, 118.26       105.76, 80.39, 51.75         101.92, 75.51, 53.15

  Unit cell (α, β, γ)    90.0, 90.0, 90.0           90.0, 90.0, 90.0           90.0, 94.72, 90.0            90.0, 98.07, 90.0

  Number of crystals     3                          2                          \~15                         \~20

  Total reflections      245867                     66707                      49321                        48659 (367)

  Unique reflections     11791 (462)                17206 (842)                13983 (623)                  10998 (256)

  Redundancy             16.6 (11.4)                3.9 (4.0)                  3.5 (1.7)                    4.4 (1.4)

  Completeness (%)       95 (96)                    98.5 (98.8)                82.1\* (36.4)                64.0\* (15.6)

  Mean I/σ(I)            6 (.61)                    6.41 (0.95)                6.25 (1.56)                  8.83 (1.45)

  R~merge~               0.171                      0.223 (1.388)              0.186                        0.185

  R~meas~                0.177                      0.270 (1.608)              0.210                        0.203

  R~pim~                 0.047                      0.133 (0.795)              0.095                        0.080

  CC~1/2~                0.99 (0.189)               0.993 (0.396)              0.984 (0.584)                0.986 (0.683)

  **Refinement**                                                                                            

  Resolution range (Å)   46.47--3.94 (4.12--3.94)   30.0--3.0 (3.05--3.00)     39.19--2.40 (2.49--2.40)     39.19--2.36 (2.44--2.36)

  R~work~                0.271 (0.253)              0.244 (0.328)              0.237 (0.269)                0.244 (0.307)

  R~free~                0.309 (0.343)              0.270 (0.394)              0.276 (0.358)                0.299 (0.437)

  Number of atoms        5764                       5979                       3219                         3115

   Protein               5761                       5812                       3012                         3012

   Ligand                3                          138                        143                          86

   Water                 \--                        29                         64                           17

  Protein residues       786                        774                        398                          398

  Ramachandran plot                                                                                         

   Favored (%)           754 (96.0)                 762 (98.4)                 389 (97.7)                   381 (95.7)

   Allowed (%)           32 (4.0)                   12 (1.6)                   9 (2.3)                      17 (4.3)

   Outliers (%)          0 (0.0)                    0 (0.0)                    0 (0.0)                      0 (0.0)

  RMS(bonds)             0.004                      0.002                      0.002                        0.002

  RMS(angles)            1.02                       0.50                       0.43                         0.57

  Average B-factor       90.3                       61.27                      73.6                         50.1

   Protein               90.3                       61.29                      73.1                         49.9

   Ligand                197.0                      66.16                      89.3                         50.7

   Water                 \--                        34.08                      63.7                         78.8

  Number of TLS groups   15                         20                         6                            7
  ------------------------------------------------------------------------------------------------------------------------------------

^\*^The G223WdN34 dataset compiled from many small crystals is 99% complete to 3.4 Å, 95% complete to 3.0 Å, 90% complete to 2.85 Å, 80% complete to 2.7 Å, and 60% complete to 2.5 Å. The G223W ΔN34 apo dataset compiled from many small crystals is 96% complete to 4.5 Å, 92% complete to 3.4 Å, 77% complete to 3.0 Å, 66% complete to 2.85 Å, and 52% complete to 2.7 Å.

Structure of G45R DraNramp reveals inward-occluded state {#s2-2}
--------------------------------------------------------

Unexpectedly, the G45R structure is not in an inward-open conformation as seen previously with our Fab-bound Patch mutant ([Figure 2A](#fig2){ref-type="fig"}) but instead adopts an inward-occluded, metal-free state ([Figure 2B](#fig2){ref-type="fig"}) that may represent an intermediate conformation between inward-open and outward-open states in the DraNramp transport cycle ([Figure 2D](#fig2){ref-type="fig"}). As in the inward-open apo state, the external vestibule remains sealed, with TM1b and TM6a forming tight hydrophobic packing with the tops of TM3 and TM10, and most TMs undergo little apparent displacement ([Figure 2F--G](#fig2){ref-type="fig"}). The major exception is TM1a, which swings \~45° to partially seal the inward aqueous cavity in the G45R structure, a motion we previously showed to be essential to the transport cycle ([@bib9]). The intracellular ends of TM4 and TM5 also move slightly compared to their position in the inward-open state, further sealing the metal-binding site from the cytosol. Comparisons of the G45R and G223W structures indicate that, rather than preventing inward motion of TM1a as we had hypothesized ([@bib9]), the G45R mutation precludes TM4-TM5 from fully closing the inner gate, as any bulkier replacement for that absolutely-conserved glycine in our outward-open G223W structure would clash with E176 on TM5. Consequently, the intracellular vestibule to the metal-binding site is highly constricted yet there is no aqueous pathway to the binding site from the external side ([Figure 2B](#fig2){ref-type="fig"}). Structural alignments with the inward-open *Staphylococcus capitis* (Sca)Nramp ([@bib18]) and outward-open EcoNramp ([@bib19]) also indicate an intermediate conformation for the G45R structure, albeit closer to the inward-open state ([Figure 2E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}), confirming our assignment as inward-occluded.

![Crystal structures of DraNramp reveal two new conformations.\
(**A**) Updated DraNramp Patch mutant structure in an inward-open apo state with a wide intracellular aqueous vestibule (red mesh) ([@bib9]). TMs 1, 5, 6, and 10 are colored gold, TMs 3, 4, 8, and 9 blue, and TMs 2, 7, and 11 gray. (**B**) The G45R structure revealed an apo inward-occluded conformation with no substantial extracellular or intracellular aqueous pathway to the metal-binding site, denoted by an \* in structures where no metal is present. (**C**) The G223W structure revealed an outward-open conformation with the physiological substrate Mn^2+^ (magenta sphere) bound at the bottom of a substantial extracellular aqueous cavity (red mesh). All structures are viewed from within the membrane. (**D**) The complete Nramp transport cycle likely consists of at least six distinct conformational states. Including the structures of *S. capitis* (Sca) ([@bib18]) and *E. coleocola* (Eco) ([@bib19]) homologs, we now have structures of five of these conformations. (**E**) Pairwise RMSD values for the superposition of the 355 Cα atoms present in all three DraNramp structures, and ScaNramp and EcoNramp. G223W superimposes best with the outward-open EcoNramp, validating our mutagenesis strategy to obtain an outward-open conformation. G45R superimposes better with the inward-open Patch mutant than outward-open G223W, suggesting it represents an inward-occluded conformation. (**F**) Superposition of Patch mutant (gold, gray, and blue) and G45R (cyan) and (**G**) RMSD calculated at each Cα. These structures superimpose well except for TM1a. TM1a's significant displacement from the inward-occluded state (G45R) to the inward-open state (Patch) is highlighted with a red arrow. (**H**) Superposition of G223W (gold, gray, and blue) and G45R (cyan) and (**I**) RMSD calculated at each Cα. The most significant rearrangements involve TMs 1b, 4, 5, 6a, and 10. These significant displacements from the inward-occluded state (G45R) to the outward-open state (G223W) are highlighted with red arrows. In panels G and I, black lines indicate average RMSD for each TM, with TMs 1, 6, and 10 divided into two halves. In panels F and H, the central view is rotated 45° along the vertical axis from the view in panels A-C, while the left and right views are 90° rotations of that central view. See also [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}.\
10.7554/eLife.41124.009Figure 2---source data 1.Nramp sequence alignment.Alignment of 6878 Nramp sequences generated with HMMER and filtered to contain only sequences with canonical Nramp TM1 'DPGN' and TM6 'MPH' motifs.](elife-41124-fig2){#fig2}

Structure of G223W DraNramp provides first metal-bound outward-open state {#s2-3}
-------------------------------------------------------------------------

The G223W structure ([Figure 2C](#fig2){ref-type="fig"}) represents an outward-open, metal-bound state that superimposes best with the outward-open EcoNramp structure ([Figure 2E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}). As predicted, the exogenous tryptophan lines a periplasmic-facing aqueous cavity leading to a bound Mn^2+^ in the center of the transporter, with close helix packing below precluding metal passage to the cytoplasm. We also determined a G223W apo structure ([Table 1](#table1){ref-type="table"}), which lacks electron density attributable to metal substrate in the binding site ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}) but is otherwise similar to the metal-bound state (Cα RMSD = 1.08 Å); hence we used the metal-bound structure for all further analyses. Compared to the inward-open and inward-occluded structures, in the outward-open state TM1b, TM6a, and the top of TM10 are splayed open, and loop 1--2 is displaced by \~4 Å, to form a wide aqueous pathway to the metal-binding site ([Figure 2H--I](#fig2){ref-type="fig"}). On the cytoplasmic side, TM4 and TM5 move significantly (by \~8 Å) straddling TM8 and approaching TM1a, while TM1a also approaches TM8 to fully shut the interior aqueous vestibule ([Figure 2H--I](#fig2){ref-type="fig"}).

Comparisons of DraNramp structures define a scaffold and flexible regions {#s2-4}
-------------------------------------------------------------------------

Based on overall superpositions of the three DraNramp structures, TMs 1, 4, 5, 6, and 10 show the largest displacements to switch metal-binding site accessibility ([Figure 2F--I](#fig2){ref-type="fig"}). The remaining TMs (2, 3, 7, 8, 9, and 11) would thus form a 'scaffold,' which adjusts to accommodate the more significant movements of the other five TMs ([Video 1](#video1){ref-type="video"}).

###### Internal rearrangements during DraNramp conformational changes.

Morph of the structure of DraNramp based on a global superimposition of the three captured conformational states. TMs 1, 5, 6, and 10 are colored gold, TMs 3, 4, 8, and 9 blue, and TMs 2, 7, and 11 gray, viewed in the membrane plane and the intracellular face pointing down. The morph starts from the G223W outward-facing conformation, transitions to the G45R occluded state, then to the Patch mutant inward-open state. The view then shifts to the intracellular face, followed by the external face, continuing to alternate back and forth through these three conformations.

10.7554/eLife.41124.010

To more objectively compare the intramolecular rearrangements that occur during the transport cycle, we calculated difference distance matrices ([@bib49]), averaged by TM, for each pair of structures ([Figure 3](#fig3){ref-type="fig"}). These matrices confirm that TMs 1, 4, 5, 6, and 10 undergo the most significant displacements relative to the rest of the protein between the different structures. But rather than moving as a rigid body such as proposed in the 'rocking bundle' model for LeuT ([@bib24]), these five TMs are also significantly displaced relative to each other.

![Distance difference matrices illustrate internal rearrangements during DraNramp conformational change.\
We calculated the pairwise Cα -- Cα distances to obtain a 398 × 398 distance matrix for each of the three DraNramp structures. To compare two structures, we generated distance difference matrices ([@bib49]), subtracting one distance matrix from the other. To simplify the data and focus on relative movements between helices, we then calculated the root-mean-squared deviations of submatrices, grouping residues within each helical segment. We used a total of 14 segments (top right), breaking TMs 1, 6, and 10 into two separate segments before and after their helix-breaking elements. The resulting 14 × 14 matrices compare (**A**) outward-open G223W and inward-occluded G45R, (**B**) inward-occluded G45R and inward-open Patch mutant, and (**C**) outward-open G223W and inward-open Patch mutant. Pairs of helices that remain stationary relative to each other have RMSD values close to 0 indicated by darker colors. In contrast, pairs of helices that rearrange significantly relative to each other have larger magnitude values indicated by lighter coloring in the heat map. These matrices show that (**A**) TMs 4, 5, 6a, and 10a undergo the greatest displacement relative both to the rest of the protein and to each other in the conformational change from inward-occluded to outward-open. (**B**) In contrast, the conformational change from inward-open to inward-occluded consists primarily of the large displacement of TM1a, with the rest of the protein remaining mainly stationary. (**C**) The comparison of the outward-open and inward-open states is essentially a sum of the two previous comparisons, with the large TM1a displacement added to the significant movements of TMs 4, 5, 6a, and 10a. The Python code used to perform the calculations and generate the resulting plots is available at GitHub: <https://github.com/GaudetLab/coarse-grained-DDMP>.](elife-41124-fig3){#fig3}

The G223W outward-open structure reveals a metal-coordination sphere distinct from the inward-open state's {#s2-5}
----------------------------------------------------------------------------------------------------------

Like other LeuT-family members, DraNramp relies on unwound regions of its TMs to bind substrates. A conserved DPGN sequence is non-helical in TM1---with the helix-breaking proline-glycine pair separating two metal-binding residues---while a conserved MPH sequence that includes the metal-binding methionine ends an unwound region in TM6 ([Figure 4A--C](#fig4){ref-type="fig"}). We used these two canonical motifs to generate an alignment of 6878 Nramp sequences ([Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}) and calculate the conservation of other important residues ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Interestingly, a third proline, P386 (83% conserved), enables the top of TM10 to swing to open the metal-binding site from the periplasm, while T228 (80%) on TM6 and N426 (99%) on TM11 stabilize the extended unwound TM6 region in the G223W structure ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}).

![Metal-coordinating interactions vary across conformational states.\
(**A**) In the G223W outward-open structure D56, N59, M230 and the A53 carbonyl, along with two water molecules, coordinate Mn^2+^. (**B**) In the inward-open ScaNramp structure (PDB: 5M95, DraNramp residue numbering) D56, N59, M230, and the A227 carbonyl coordinate Mn^2+^. (**C**) In the G45R inward-occluded structure D56, N59, M230, Q378, and the A53 and A227 carbonyls are all close, suggesting that all six could simultaneously coordinate the metal substrate in a hypothetical similar Mn^2+^-bound conformation. Three conserved helix-breaking prolines on TM1 (P57), TM6 (P231), and TM10 (P386) confer the flexibility needed for the metal-binding site. The TM6 unwound region is extended in the outward-open state, while TM10 bends more dramatically at P386 in the inward-oriented states to close outside access to the metal-binding site. For clarity, TMs 3, 4, 5, 8, and 9 are omitted in panels A-C. (**D**) Schematic for liposome transport assay to measure Mn^2+^ or Cd^2+^ uptake. (**E--F**) Plots of initial rates vs. (**E**) Cd^2+^ or (**F**) Mn^2+^ concentration used to determine Michaelis-Menten constants (Table inset) for WT DraNramp and binding-site mutants. All mutants significantly impaired Mn^2+^ transport at lower \[Mn^2+^\], while only Q378 mutants did not severely impair Cd^2+^ transport. Data are averages ± S.E.M. (n = 3); errors on K~M~ and V~max~ reflect uncertainty of the fit (shown as solid lines on the graphs) to the data. For WT and Q378 mutants we observed a reduced transport rate at high \[Cd^2+^\], which we did not include in the K~M~/V~max~ fitting. These data are intriguing and remain unexplained, as we do not observe a similar effect for Mn^2+^, and we do not see an obvious second regulatory metal-binding site in our current structures of DraNramp. See also [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.](elife-41124-fig4){#fig4}

The inward-open ScaNramp structure revealed a metal-binding site consisting of three conserved sidechains corresponding to D56, N59, and M230 in DraNramp, and a backbone carbonyl of A227 ([Figure 4B](#fig4){ref-type="fig"}) ([@bib18]). In outward-open DraNramp, a Mn^2+^ binds both D56 and M230 (2.9 and 3.0 Å), with N59 slightly further away (3.4 Å) ([Figure 4A](#fig4){ref-type="fig"}). The increased unwinding of TM6a displaces the A227 carbonyl too far (6.5 Å) to coordinate the metal ([Figure 4---figure supplement 1A--B](#fig4s1){ref-type="fig"}). Instead, the A53 carbonyl coordinates the Mn^2+^ (2.0 Å)---our structure is thus the first to implicate this residue in the metal transport cycle. Interestingly, A53 and A227 are at analogous positions within the two inverted repeats of the LeuT fold. Two waters (2.7 and 2.8 Å) complete a Mn^2+^-coordination sphere. While the resolution remains too low to definitively define the coordination geometry, the electron density is consistent with Mn^2+^ interacting with both D56 oxygens and thus seven total ligands---rare but not unprecedented for Mn^2+^ ([@bib4]; [@bib26]). An ordered water network expands into the external vestibule as part of the extended metal coordination sphere ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). A water is also tethered to the conserved H232 directly below the metal-binding M230, perhaps poised to hydrate the cation upon conformational change.

The G45R inward-occluded structure suggests potential metal-binding role for conserved Q378 {#s2-6}
-------------------------------------------------------------------------------------------

The inward-occluded G45R binding site contains no metal. The A53 carbonyl is farther from the other metal-binding residues than the A227 carbonyl ([Figure 4C](#fig4){ref-type="fig"}). This is consistent with a model in which Nramp metal transport involves a switch of ligands, perhaps with the A53 and A227 carbonyls both coordinating the metal substrate in an as-yet-uncaptured intermediate state.

In G45R, flexing of TM10 above its P386 pivot shifts Q378 (86% conserved, with another 11% of sequences, including HsNramp2, having an N at this position) \~5 Å to within hydrogen-bonding distance of metal-binding A227 and D56, perhaps stabilizing the negative charge on a deprotonated D56 during the empty transporter's return to outward-open. While Q378 does not bind the metal substrate in either outward DraNramp (7.9 Å) or inward ScaNramp ([@bib18]) (4.5 Å), its position in the G45R occluded intermediate suggests it may transiently bind during the transport process. Indeed, two independent molecular dynamics (MD) simulations of the inward-open ScaNramp showed a metal interaction with the Q378 oxygen ([@bib8]; [@bib47]), and mutations at this position impaired metal transport in HsNramp2 ([@bib47]).

To test the importance of the three conserved sidechains that coordinate Mn^2+^ (D56, N59, and M230; [Figure 4A--B](#fig4){ref-type="fig"}) and Q378 to metal transport, we purified a panel of mutants and reconstituted them into proteoliposomes ([Figure 4D](#fig4){ref-type="fig"}). D56A and D56N eliminated Mn^2+^ and Cd^2+^ transport ([Figure 4E--F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1C--D](#fig4s1){ref-type="fig"}), confirming the importance of D56. N59A severely and N59D moderately reduced transport of both metals ([Figure 4E--F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1C--D](#fig4s1){ref-type="fig"}). Both M230A and M230T transport both metal substrates ([Figure 4---figure supplement 1C--D](#fig4s1){ref-type="fig"}), but with lower apparent affinity than WT ([Figure 4E--F](#fig4){ref-type="fig"}). Consistent with our previous findings, removing M230---the lone sulfur-containing metal-binding residue---affects Cd^2+^ more than Mn^2+^ transport, reflecting the importance of the semi-covalent interaction Cd^2+^ can form with sulfur ([@bib8]). Lastly, Q378S and Q378N both preserved significant transport of both metals ([Figure 4---figure supplement 1C--D](#fig4s1){ref-type="fig"}). However, these mutants increased the K~M~ for Mn^2+^---but interestingly not Cd^2+^ ([Figure 4E--F](#fig4){ref-type="fig"}). That the native glutamine is essential for efficient transport of the biological substrate Mn^2+^ but dispensable for Cd^2+^ uptake ([Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}) suggests that the two metals interact differently with their surrounding ligands during the transport process, corroborating the differential effects of M230 mutations.

DraNramp proton transport does not require large conformational change {#s2-7}
----------------------------------------------------------------------

We reconstituted G45R and G223W into proteoliposomes to assess their metal and proton transport ([Figure 5A](#fig5){ref-type="fig"}). Consistent with our in vivo findings, neither G45R nor G223W transported Mn^2+^, Cd^2+^, or Co^2+^ ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A--B](#fig5s1){ref-type="fig"}). Surprisingly, in the presence of a favorable negative membrane potential established using K^+^ gradients and the K^+^-ionophore valinomycin, G223W enabled larger basal H^+^ influx than WT, while G45R had no H^+^ flux ([Figure 5C](#fig5){ref-type="fig"}). Interestingly, while Mn^2+^ transport stimulated H^+^ uptake for WT, adding Mn^2+^ did not further stimulate either G45R or G223W ([Figure 5C](#fig5){ref-type="fig"}). These results suggest that Nramp metal and proton transport can proceed via separate routes, with proton transport requiring only that the protein sample the outward-open state.

![Outward-locked mutants retain H^+^ transport ability.\
(**A**) Proteoliposome assay schematic for monitoring M^2+^ and H^+^ import. Membrane potential (ΔΨ) was established using K^+^ gradients and valinomycin. (**B**) Mn^2+^ uptake over time; WT enabled robust uptake while G45R and G223W showed no activity. NoP = No Protein control liposomes. (**C**) H^+^ uptake over time; WT enabled significant H^+^ uptake without metal (H^+^ uniport), further stimulated by Mn^2+^. G223W showed a larger H^+^ uniport rate, but Mn^2+^ provided no enhancement; G45R showed no H^+^ transport activity. Traces are representative of four experiments. (**D**) Schematic for in vitro cysteine modification of A53C (inside accessible) and A61C (outside accessible). MTSEA and NEM are membrane permeable, whereas permanently-charged MTSET is not. (**E,G**) Mn^2+^ and (**F,H**) H^+^ transport over time in the presence or absence of cysteine modifying agents. Adding ionomycin allows divalent cation entry to achieve maximum signal. Traces are representative of three experiments. See also [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"}, [2](#fig5s2){ref-type="fig"} and [3](#fig5s3){ref-type="fig"}.](elife-41124-fig5){#fig5}

To test this new hypothesis, we reconstituted the A53C and A61C mutants, with single cysteines located just below or above the metal-binding site respectively ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). Both retain significant metal transport ([Figure 5E,G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E--F](#fig5s1){ref-type="fig"}), and can be targeted with cysteine-specific modifiers to post-translationally add bulky and/or charged wedges to impede conformational change ([Figure 5D](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Charged, and thus membrane-impermeable, MTSET nearly eliminated metal transport by A61C, while uncharged NEM or MTSEA moderately impaired or did not affect transport, respectively ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}), a result consistent with our previous in vivo findings that adding steric bulk, but not formal charge, is tolerated at this position ([@bib9]). In addition, MTSET-treated A61C replicated G223W's H^+^-transport behavior, with higher H^+^ uniport compared to unmodified transporter, but little stimulation by Mn^2+^ ([Figure 5F](#fig5){ref-type="fig"}). In contrast MTSET had no effect on Mn^2+^ and Cd^2+^ transport by A53C, but membrane-permeable MTSEA and NEM both eliminated transport ([Figure 5G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}). Regarding H^+^ uptake, MTSEA- and NEM-treated A53C resembled G45R, with no basal uniport or Mn^2+^ stimulation, while again unmodified and MTSET-treated A53C both behaved similarly to WT ([Figure 5H](#fig5){ref-type="fig"}). These findings show that essentially all activity in proteoliposomes comes from outside-out DraNramp. MTSET, which should inhibit any inside-out A53C, did not affect transport ([Figure 5G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}), indicating that inside-out transporters contribute negligibly to the total activity in this assay. Consistently, while MTSET treatment spares inside-out A61C from labeling, it nevertheless nearly eliminated metal transport ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}), further supporting the assertion that outside-out WT-like transporters provided most of the detected transport activity. To confirm that a mix of inside-out and outside-out transporters were indeed present in proteoliposomes, we assessed the susceptibility of DraNramp to thrombin cleavage at a naturally-occurring site ([@bib25]) in the protein's non-conserved, disordered N-terminal region ([Figure 5---figure supplement 2A--C](#fig5s2){ref-type="fig"}). While thrombin fully cleaved DraNramp in detergent, in proteoliposomes the cleaved protein population plateaued at \~50% ([Figure 5---figure supplement 2D--F](#fig5s2){ref-type="fig"}). This cleaved portion likely corresponds to inside-out oriented protein with an exposed N-terminal region, with the remaining \~50% of protein therefore outside-out oriented with the N-terminus inside the liposome and thus protected from thrombin cleavage ([@bib58]; [@bib59]).

In summary, these experiments with permanently-locked crystallization constructs or chemically-locked cysteine mutants demonstrated that while metal transport requires complete conformational cycling, proton transport does not require large-scale conformational change and can proceed through DraNramp's outward-open state but not its inward-open state. In addition, metal transport through DraNramp is much more efficient in the outside-to-inside direction than in the inside-to-outside direction under the physiological-like conditions set up in our in vitro assay.

Conserved salt-bridge network provides potential proton pathway to cytoplasm {#s2-8}
----------------------------------------------------------------------------

Our in vitro results suggested that proton transport occurs via a pathway separate from the intracellular metal-release vestibule, which remains closed to bulk solvent in the proton-transporting G223W mutant. Below the metal-binding site begins a network of highly-conserved hydrophilic residues, including at least seven potentially protonatable sidechains, that leads from the metal-binding D56 through a tight corridor between TMs 3, 4, 8, and 9 to the cytoplasm ([Figure 6A--C](#fig6){ref-type="fig"}). In contrast to the external and intracellular vestibules proposed as metal entrance and release pathways, the helices and residues within this polar network undergo little rearrangement between the three DraNramp structures, except the intracellular end of TM4 ([Figures 2F--I](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}).

![Conserved salt-bridge network provides pathway for proton uniport.\
(**A**) View from an angle above the membrane looking down into the extracellular aqueous cavity in the outward-open G223W structure. (**B**) Zoomed-in view (with TM10 and TM11 omitted for clarity) and (**C**) schematic showing a network of conserved protonatable residues that originates from the metal-binding site and extends into the cleft between TMs 3, 4, 8, and 9. H232 and E134 abut metal-binding M230 and D56, providing a connection to the D131-R353 and R352-E124 salt-bridge pairs. (**D**) pK~a~ estimates by PROPKA ([@bib16]) from high-resolution DraNramp structures. (**E**) Initial rates of basal H^+^ uptake at various ΔΨs (averages ± S.E.M.; n ≥ 4). Mutations to D56, E134, H232, and D131 eliminated H^+^ uniport observed for WT. N59 and M230 mutants retained significant H^+^ uptake. Mutations to E124, R352, and R353 enhanced H^+^ uniport. (**F**) Dose-response curve of outward-open reporter A61C modification versus NEM concentration. All mutants except H237Q sampled the outward-open state, which is required for H^+^ transport to occur ([Figure 5](#fig5){ref-type="fig"}). Data are averages ± S.E.M. (n ≥ 3). (**G**) Salt-bridge network schematic shows clustering of four residues required for H^+^ uniport (red) as well as three residues that may restrain this flux (green). See also [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}.](elife-41124-fig6){#fig6}

Highly-conserved residues surrounding the metal-binding D56 include H232 on TM6b (100% as defined) and E134 (TM3, 98%)---which have each been proposed as the Nramp proton transfer point ([@bib19]; [@bib47]). Across from E134 lies a conserved salt-bridge pair: D131 (TM3, 93%) and R353 (TM9, 78%). Approximately 9 Å below, a second conserved salt-bridge, E124-R352 (94% and 87%), links the same two helices. This network could provide the route for proton uniport in the outward-open conformation.

Two conserved aspartates anchor the DraNramp proton transport pathway {#s2-9}
---------------------------------------------------------------------

To assess whether these residues could be proton carriers, we calculated predicted pK~a~ values for our outward-open and inward-occluded structures ([Figure 6D](#fig6){ref-type="fig"}) ([@bib16]). Surprisingly, D56 is the only residue with a pK~a~ in the ideal 6--7 range to facilitate proton exchange at a typical external pH. About 4 Å from D56, E134's high pK~a~ (\~11.5) indicates a near permanently-protonated state, while H232---4 Å below E134 and 7 Å from D56---has too low a pK~a~ (\~3.5) to easily protonate, as does H237 (\~4.0) further down TM6b. While E134 and H232 have separately been suggested as the Nramp proton-binding site ([@bib19]; [@bib47]), our pK~a~ predictions suggest otherwise, as maintaining a formal change, especially on a histidine, would not be favorable in the protein core. In addition, previous studies showed the analogous E-to-Q mutant in EcoNramp maintained WT-like proton transport ability ([@bib19]) as did the analogous H-to-A mutant in rat Nramp2 ([@bib36]), which argues against those two residues as essential transfer points if the Nramp family shares a common transport mechanism. Within the TM3-TM9 salt-bridge network, R352 and R353 are likely protonated and positively charged, while their respective partners E124 and D131 are likely deprotonated and negatively charged. The predicted pK~a~ values of D131 and E124 indicate their amenability to protonation. Indeed, as D56's predicted pK~a~ drops to 3.2 with Mn^2+^ bound, D131 becomes the best candidate to receive a proton.

We observed three distinct voltage-driven H^+^ transport phenotypes within a panel of mutants to highly-conserved residues ([Figure 6E](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). First, removing either metal-binding residue N59 or M230 had little effect. Second, neutralizing any member of the D56-E134-H232-D131 network or the H237Q mutation drastically reduced H^+^ transport. Third, mutating any of E124, R352, R353---farthest from D56---increased H^+^ uniport across multiple voltages.

Outward-reporter A61C accessibility ([Figure 1C](#fig1){ref-type="fig"}) is consistent with each mutant sampling the outward-open state needed for proton transport ([Figure 5](#fig5){ref-type="fig"}), ruling out a conformation-locking explanation for the loss-of-function mutants. While some mutations perturbed the transporter's conformational preference, A61C remained at least somewhat accessible in all cases except H237Q ([Figure 6F](#fig6){ref-type="fig"}).

In summary, based on our H^+^ transport measurements, structure-calculated residue pK~a~ values, and prior studies using mutants of other Nramp homologs, D56 is the likely initial protonation point, with E134 and H232 positioned to chaperone the proton transfer to D131, while R352, R353, and E124 restrain this process ([Figure 6G](#fig6){ref-type="fig"}).

Discussion {#s3}
==========

We propose a structure-based model for conformation cycling in DraNramp ([Figure 7A--B](#fig7){ref-type="fig"}). Starting from the outward-open state seen in our G223W structure ([Figure 7A](#fig7){ref-type="fig"}, left panel), metal binding (and perhaps resulting proton entry into its release pathway) may trigger bulk conformational rearrangement (see below for details). To close the external vestibule, TM6a, TM10, and to a lesser extent TM1b move closer to each other above their respective non-helical hinge regions, with the TM6a movement propagated through the TM5-6 linker to reorient TM5 and thus begin to open the inner gate. From this transient occluded conformation similar to our G45R structure ([Figure 7A](#fig7){ref-type="fig"}, middle panel), additional movement of TM4-TM5 allows TM1a to bend upward to fully open the inner gate, enabling solvent access to and release of the metal, as the protein achieves a state similar to the Patch mutant DraNramp structure ([Figure 7A](#fig7){ref-type="fig"}, right panel) ([@bib9]). Analogously, to return to the outward-open state and complete the transport cycle, TM1a swings in to reach a conformation similar to G45R, then TM4-TM5 fully close on TM1a to seal the cytoplasmic vestibule while TM1b, TM6a, and TM10 separate to open the external vestibule.

![Mechanistic models for conformational change, proton transport, and metal transport.\
(**A**) Model of conformational change: The metal ion reaches the outward-open binding site via the vestibule between TMs 1b, 6a, 10, 3, and 8. TM6a and 10 bend inward to close the vestibule in the inward-occluded conformation. TM6a's inward bend pulls on TM5 via extracellular loop 5--6 to initiate opening of the inner gate. Finally, TM1a swings away from TM6b to open the intracellular vestibule into which the metal diffuses. (**B**) Superposition of outward- (gold) and inward-open (teal) conformations illustrate key movements by TMs 1, 5, 6, and 10. (**C**) Overall DraNramp transport model under prevailing physiological conditions (negative inside membrane potential, acidic-outside pH gradient): While metal transport requires complete conformational cycling, proton uniport occurs through the outward-open state. Metal-stimulated proton transport may follow the same pathway as proton uniport. (**D**) Proton transport model: A proton transits the external vestibule to reach the binding site near the membrane center and initially binds to D56. Metal enters through the same passageway, ejecting the proton, which then passes to D131, with H232 and E134 facilitating the transfer. The proton ultimately reaches the cytoplasm through the polar network between TMs 3, 4, 8, and 9, while the metal must await a bulk conformational change that opens a separate pathway between TMs 1a, 2, 5, 6b, 7, and 8. Proton uniport follows the same route, with the D56-D131 transfer occurring at a slower rate without metal substrate. (**E**) Model for metal coordination during the transport process: the metal initially binds in the outward-open state to D56, N59, M230 sidechains and the A53 carbonyl, shedding all but two water ligands. As the outward metal-permeation pathway closes, Q378 and the A227 carbonyl displace the waters so that the metal is fully coordinated by six amino acids in the inward-occluded state. As the inner gate opens, Q378 and the A53 carbonyl withdraw and are replaced by waters. The metal is then released into the cytoplasmic aqueous vestibule. To facilitate the return to the outward-open state, Q378 and N59 donate hydrogen bonds to negatively-charged D56 in the inward-occluded return conformation seen in our G45R structure. Finally, as the transporter returns to an outward-open state, it may bind a proton in preparation for metal-binding. For the inward-open metal-bound model for DraNramp, we altered the reported coordination from the Mn^2+^-bound ScaNramp relatively low-resolution (3.4 Å) crystal structure (PDB: 5M95) by adding two metal-coordinating waters, as well as switching the aspartate coordination to bidentate and the asparagine coordination to monodentate to be consistent with our G223W structure.](elife-41124-fig7){#fig7}

Our in vitro assays showed that while DraNramp metal transport requires sampling of both outward- and inward-open states, proton uniport occurs in sterically outward-locked constructs ([Figures 1](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"}). This supports a model where protons and metal travel through distinct pathways on the cytoplasmic side of the protein ([Figure 7C--D](#fig7){ref-type="fig"}), such that proton uniport is a feature of DraNramp's outward-open state, whereas metal transport requires bulk rearrangement. In contrast, both protons and metal likely enter through the same aqueous pathway, as inward-locked proteins do not transport either substrate. From structure-based pK~a~ calculations ([Figure 6D](#fig6){ref-type="fig"}), H^+^-transport data for a large panel of mutants to conserved protonatable residues in DraNramp ([Figure 6E](#fig6){ref-type="fig"}), and previous mutagenesis studies with other Nramp homologs ([@bib19]; [@bib36]; [@bib47]), we propose that proton uniport occurs via a network of conserved protonatable residues leading from D56 in the metal-binding site to D131 in a salt-bridge network between TMs 3, 4, 8, and 9. This proton pathway is accessible in the outward-open state, thus enabling the well-documented proton uniport ([@bib13]; [@bib27]; [@bib36]; [@bib42]; [@bib66]). The proton uniport---common to the general Nramp family---that occurs under physiological conditions wastes electrochemical energy by dissipating the transmembrane proton gradient without contributing to metal uptake. Considering the relatively low abundance and slow kinetics of Nramp transporters, this proton uniport property may be an evolutionarily-tolerated consequence of the transporter's design, or it could instead confer an as-yet-undetermined functional advantage. The predicted protonation of D56 and subsequent transfer to D131, mediated through an E134/H232-stabilized transition state, may however serve to restrain H^+^ entry. For metal-stimulated proton transport, Mn^2+^ binding likely stimulates proton transfer into the same salt-bridge network, perhaps by directly ejecting a proton from D56 in the metal-binding site. Indeed, in a separate study we show that neutralizing mutations to the same four residues that eliminated H^+^ uniport ([Figure 6E](#fig6){ref-type="fig"}) also eliminated (D56, D131, H232) or severely reduced (E134) H^+^ fluxes in the presence of added Mn^2+^, with mutants to D131, E134, and H232 retaining significant metal transport despite a lack of proton transport ([@bib10]). However, the precise order of events for proton and metal transport, including whether it is indeed a thermodynamically coupled symport mechanism, remains undetermined, and additional transport mechanisms are possible.

In our G223W structure, two water molecules coordinate Mn^2+^: one lies between the metal and A227's carbonyl, the other the metal and Q378 ([Figures 4A](#fig4){ref-type="fig"} and [7E](#fig7){ref-type="fig"}). We propose that after Mn^2+^ binds to D56, M230, A53, and N59 as in our G223W structure, the A227 carbonyl and Q378 both displace the two waters as the outer gate closes. DraNramp would thus reach a fully dehydrated metal-bound state not yet visualized but which may resemble our apo G45R inward-occluded structure ([Figure 7E](#fig7){ref-type="fig"}). Next, as the inner gate opens, the A53 carbonyl would exchange with a nearby water---such as the one bound to H232 in our G223W structure---as would Q378, to yield an inward-open metal-bound state similar to the ScaNramp structure ([Figures 4B](#fig4){ref-type="fig"} and [7E](#fig7){ref-type="fig"}) ([@bib18]). In this conformation the Mn^2+^-coordination sphere would include four residues and two waters---analogous to the G223W structure---thus facilitating eventual metal release. The proposed transition from four to six to four Mn^2+^-coordinating residues could help preferentially stabilize the occluded transition state ([@bib54]) through the free energy (entropy-driven) gains of releasing the two water ligands. Furthermore, the rearrangements needed to achieve the hypothetical intermediate six-residue Mn^2+^ coordination---the helical extension and inward movement of TM6a, and the toppling of TM10's top half---also close the external vestibule, providing a potential mechanistic link between local metal-coordination changes and bulk conformational change. To return to the outward-open state, the transporter must pass through an apo-occluded state as seen in the G45R structure, in which the N59 and Q378 sidechains reorient to stabilize D56 in the absence of the divalent cation carried during the outward-to-inward transition ([Figures 4C](#fig4){ref-type="fig"} and [7E](#fig7){ref-type="fig"}). As the transporter reaches the outward-open state seen in EcoNramp ([@bib19]) and our apo G223W structure, a protonation event at D56 may prime the binding site to receive another incoming metal ion. Future molecular dynamic simulations and/or experiments will be essential to test these predictions.

The mechanism described above for the DraNramp transport cycle---developed from structures of the same Nramp homolog in three distinct conformations and supported by metal and proton transport data---differs significantly from those previously observed for other LeuT-fold transporters. Mhp1, BetP, and (to a lesser degree) LeuT generally obey a 'rocking bundle' model in which the rigid-body movement of four TMs that contain the primary substrate binding site (1, 2, 6, and 7) against the remaining TMs (3-5, 8-10) leads to conformational change ([@bib24]; [@bib32]; [@bib52]). In DraNramp TMs 4, 5, and 10 join TMs 1 and 6 to form the substrate-binding 'mobile domain,' while TMs 2 and 7 join the remaining TMs as part of the scaffold. Furthermore, the mobile helices do not move as rigid bodies, as conserved helix-breaking motifs free TMs 1a, 6a, and the top of TM10 to move independent of TMs 1b, 6b and the bottom of TM10. In contrast, the fully-helical TM5 wholly reorients, and may thus coordinate the opening and closing of the inner and outer gates, connecting TMs 1a, 4, and 6b with TM6a ([Figures 2](#fig2){ref-type="fig"} and [7A--B](#fig7){ref-type="fig"}).

In comparison to other APC superfamily members, the large TM1a displacement in DraNramp most closely resembles its dramatic movement in LeuT ([@bib33]). Gating roles for TMs 5 and 10 have been ascribed for BetP, Mhp1, and MhsT ([@bib37]; [@bib48]; [@bib55]), although not as extensive as we propose here in DraNramp. Not surprisingly, the DraNramp conformational changes are most similar to those predicted by comparing structures of two other bacterial Nramp homologs in complementary conformations ([@bib18]; [@bib19]), suggesting conservation within the Nramp clade of the LeuT-fold family.

Whereas the distinct conformational changes of DraNramp demonstrate the diverse repertoire of dynamics available to the LeuT-fold family, the most striking mechanistic differences between DraNramp and other structurally-studied LeuT-fold transporters concern the substrate transport routes. Most well-characterized members (including LeuT, BetP, and Mhp1) are Na^+^-driven symporters of small organic molecules which have one or two Na^+^-binding sites ([@bib45]; [@bib50]). Sodium binding at the highly-conserved Na2 site connects the 'bundle' (TM1) and 'scaffold' (TM8) domains while also shifting the conformational equilibrium to favor the outward-open state ([@bib14]; [@bib57]; [@bib69]). This Na2 site consists of hydroxyls from two consecutive serines/threonines on TM8 and four main-chain carbonyls (one from TM8, three from the unwound-region of TM1) ([@bib45]; [@bib67]). Intriguingly, the analogous location in DraNramp also contains highly-conserved hydroxyl-providing TM8 residues S327 (92%) and S328 (20% conserved, with another 74% as T), which may be remnants of the ancestral Na2 site conversion into a H^+^ site in the Nramp clade. This hypothetical evolutionary switch has precedent within the LeuT-fold family, as the proton-coupled amino acid transporter ApcT analogously uses a conserved TM5 lysine (K158), whose sidechain protrudes into the Na2 location, as its primary proton-binding site ([@bib51]). The sodium-to-proton switch may have evolved in Nramps to avoid simultaneously coordinating two metal cations (Na^+^ coordination, like Mn^2+^ coordination, requires \~6 oriented ligands, whereas H^+^ binding requires a single sidechain).

LeuT and other bacterial homologs also antiport a proton as they return to an outward-open state ([@bib29]; [@bib68]; [@bib70]) via a conserved glutamate (E290) on TM7 ([@bib38]), analogous to the highly-conserved N275 (100%) that lines DraNramp's intracellular vestibule. Available structures and MD simulations suggest that proton symport in ApcT and antiport in LeuT likely occur through the bulk opening and closing of the same permeation pathways used by the primary substrates (amino acids) ([@bib33]; [@bib38]; [@bib51]; [@bib53]). In contrast DraNramp does H^+^ uniport even when mutationally (G223W) or chemically (A61C-MTSET) precluded from opening the intracellular vestibule ([Figure 5](#fig5){ref-type="fig"}). We propose a proton route from D56 through D131 and into a conserved salt-bridge network between TMs 3, 4, 8, and 9 ([Figure 6](#fig6){ref-type="fig"}), which remain relatively stationary during the conformational change process ([Figure 2](#fig2){ref-type="fig"}). Indeed, evolutionary analysis reveals that this polar network is unique to the Nramp clade of the LeuT-family ([@bib12]); this region is mainly hydrophobic in both LeuT and ApcT ([@bib51]; [@bib67]). A parallel transport pathway for protons could alleviate the electrostatic problem of simultaneously stabilizing three added positive charges (the proton and divalent metal cation) in close proximity throughout a conformational change process, although other unrelated transporters are known to accommodate multiple positive charges within their binding sites during the transport cycle ([@bib62]). The observed proton uniport in Nramp, requiring only subtle conformational rearrangements, is more reminiscent of H^+^ shuttling in the CLC family of Cl^-^/H^+^ antiporters ([@bib1]; [@bib2]; [@bib6]; [@bib40]) than the canonical Na^+^ transport seen in LeuT-family symporters.

It remains to be demonstrated whether the observed Nramp metal and proton transport truly constitute symport. The DraNramp proton and metal transport mechanism we outline, where primary and driving substrates enter via a common permeation pathway but exit via separate routes to the cytoplasm---with H^+^ transfer perhaps triggering bulk conformational rearrangement needed for Mn^2+^ release to occur if the substrates are in fact coupled---is thus far unique to the Nramp clade within the APC superfamily. This new model for Nramp transport therefore illustrates the evolutionary flexibility and adaptability of the shared LeuT fold.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                          Designation                         Source or reference                                              Identifiers
  (species) or resource                                                                                                                       
  -------------------------------------- ----------------------------------- ---------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene (*Deinococcus radiodurans*)       DraNramp                            Genomic DNA                                                      Uniprot: Q9RTP8

  Strain (*Escherichia coli* C41(DE3))   C41(DE3)                            Lucigen                                                          60442--1

  Recombinant DNA reagent                pET21a                              Novagen                                                          69740--3

  Antibody                               Alexa 647-conjugated anti-His-tag   Qiagen                                                           35370

  Chemical compound                      DDM                                 Anatrace                                                         D310S

  Chemical compound                      DM                                  Anatrace                                                         D322S

  Chemical compound                      LMNG                                Anatrace                                                         [NG310](https://www.anatrace.com/Products/Detergents/NG-CLASS/NG310)

  Chemical compound                      Monoolein                           Anatrace                                                         [LCP18](https://www.anatrace.com/Products/Specialty-Detergents-Products/LCP/LCP18)

  Chemical compound                      Fura-2                              Life Technologies                                                [F-1200](http://www.lifetechnologies.com/order/catalog/product/F1200)

  Chemical compound                      BCECF                               VWR                                                              [102987](https://us.vwr.com/store/catalog/product.jsp?catalog_number=102987-506)[--](https://us.vwr.com/store/catalog/product.jsp?catalog_number=102987-506)[506](https://us.vwr.com/store/catalog/product.jsp?catalog_number=102987-506)

  Chemical compound                      POPE                                Avanti Polar Lipids                                              [850757](https://www.avantilipids.com/index.php?Itemid=229&catnumber=850757&id=571&option=com_content&view=article)[C](https://www.avantilipids.com/index.php?Itemid=229&catnumber=850757&id=571&option=com_content&view=article)

  Chemical compound                      POPG                                Avanti Polar Lipids                                              840457C

  Chemical compound                      Valinomycin                         Sigma-Aldrich                                                    V0627

  Chemical compound                      5K-PEG maleimide                    Creative PEGWORKS                                                PLS-234

  Chemical compound                      NEM                                 Sigma-Aldrich                                                    4260

  Chemical compound                      MTSET                               VWR                                                              89139--738

  Chemical compound                      MTSEA                               VWR                                                              89139--740

  Software, algorithm                    HKL2000                             PMID: [27799103](https://www.ncbi.nlm.nih.gov/pubmed/27799103)   RRID:[SCR_015547](https://scicrunch.org/resolver/SCR_015547)

  Software, algorithm                    XDS                                 PMID: [20124692](https://www.ncbi.nlm.nih.gov/pubmed/20124692)   RRID:[SCR_015652](https://scicrunch.org/resolver/SCR_015652)

  Software, algorithm                    PHASER                              PMID: [19461840](https://www.ncbi.nlm.nih.gov/pubmed/19461840)   RRID:[SCR_014219](https://scicrunch.org/resolver/SCR_014219)

  Software,\                             PHENIX                              PMID: [22505256](https://www.ncbi.nlm.nih.gov/pubmed/22505256)   RRID:[SCR_014224](https://scicrunch.org/resolver/SCR_014224)
  algorithm                                                                                                                                   

  Software, algorithm                    coot                                PMID: [20383002](https://www.ncbi.nlm.nih.gov/pubmed/20383002)   RRID:[SCR_014222](https://scicrunch.org/resolver/SCR_014222)

  Software, algorithm                    PyMOL                                                                                                RRID:[SCR_000305](https://scicrunch.org/resolver/SCR_000305)

  Software, algorithm                    PROPKA                              PMID: [15215472](https://www.ncbi.nlm.nih.gov/pubmed/15215472)   

  Software, algorithm                    HMMER                               PMID: [21593126](https://www.ncbi.nlm.nih.gov/pubmed/21593126)   RRID:[SCR_005305](https://scicrunch.org/resolver/SCR_005305)

  Software, algorithm                    MUSCLE                              PMID: [19461840](http://www.ncbi.nlm.nih.gov/pubmed/19461840)    RRID:[SCR_011812](https://scicrunch.org/resolver/SCR_011812)

  Software, algorithm                    ImageJ64                                                                                             RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)

  Software, algorithm                    MATLAB                                                                                               RRID:[SCR_001622](https://scicrunch.org/resolver/SCR_001622)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cloning of DraNramp {#s4-1}
-------------------

WT and mutant DraNramps were cloned in pET21-N8H as described ([@bib9]). All constructs were full-length, except the G223W crystallization construct was N-terminally truncated to residue 35; this deletion did not affect metal transport ([@bib9]). Mutations were made using the Quikchange mutagenesis protocol (Stratagene) and confirmed by DNA sequencing. Single-cysteine constructs also included the C382S mutation to remove the lone endogenous cysteine. The C41(DE3) *E. coli* strain was used for protein expression and in vivo assays.

Expression and purification of DraNramp crystallography constructs {#s4-2}
------------------------------------------------------------------

Six liters of DraNramp C41(DE3) cells were cultured as described ([@bib9]), pelleted and flash-frozen in liquid nitrogen. Proteins were purified at 4°C. Thawed cells were lysed by sonication in 40 mL load buffer (20 mM sodium phosphate, pH 7.5, 55 mM imidazole, 500 mM NaCl, 10% (v/v) glycerol) plus 1 mM PMSF, 1 mM benzamidine, and 0.3 mg/mL each DNAse I and lysozyme. Lysates were cleared for 20 min at 27,000 × *g*. Membranes were pelleted from supernatant at 230,000 × *g* for 70 min, homogenized in 65 mL load buffer and flash-frozen in liquid nitrogen. Thawed membranes were solubilized for 1 hr, adding 1.5% (w/v) n-dodecyl-β-D-maltopyranoside (DDM), then spun at 140,000 × *g* for 35 min to pellet debris. Pre-equilibrated Ni-sepharose beads (3 mL; GE Healthcare) were incubated with the supernatant for 1 hr, and washed with load buffer containing sequentially 0.03% DDM, 0.5% lauryl maltose neopentyl glycol (LMNG), and 0.1% LMNG. Protein was eluted in 20 mM sodium phosphate, pH 7.5, 450 mM imidazole, 500 mM NaCl, 10% (v/v) glycerol, 0.01% LMNG, concentrated to \<0.5 mL in a 50 kDa cutoff centrifugal concentrator, and loaded onto a Superdex S200 10/300 (GE Healthcare) pre-equilibrated with SEC buffer (10 mM HEPES pH 7.5, 150 mM NaCl, 0.003% LMNG). Peak fractions were pooled, concentrated to \~20--40 mg/mL, aliquoted, and flash-frozen in liquid nitrogen.

DraNramp crystallization, X-ray diffraction data collection, and structure determination {#s4-3}
----------------------------------------------------------------------------------------

Protein (10--15 μL) was loaded into a 100 μL glass syringe attached to an LCP coupling device (Formulatrix). A second 100 μL syringe containing 1.5 volumes of liquid monoolein (T \> 37°C) was attached to the coupling device, and the two solutions were mixed for 100 cycles using an NT8 (Formulatrix) in LCP mixing mode at 5 mm/s. LCP boluses (50--100 nL) and precipitant (600--1000 μL) were dispensed into 96-well LCP glass plates and incubated at room temperature (RT). Crystals of G223W (25 mg/mL) with 2.5 mM MnCl~2~ in SEC buffer grown in 28% PEG400, 5 mM MnCl~2~, 100 mM MES pH 6, 50 mM succinic acid pH 6, 10 mM spermidine pH 7, (10--30 μm square plates) were harvested after nine days using mesh loops (MiTeGen) to scoop the bolus, then flash-frozen in liquid nitrogen. Similar G223W crystals in the apo state were obtained after seven days with 26% PEG400, 100 mM MES pH 6, 50 mM succinic acid pH 6, 20 mM spermidine pH 7. Crystals of the analogous NEM-modified G223C/C382S ∆N34 (G223C retains close to WT-level metal transport before NEM-labeling ([@bib9])) were obtained in the same condition. Crystals of G45R (22 mg/mL) grown in 20% PEGMME 550, 150 mM NaCl, 100 mM HEPES, pH 7.0 (\~100 μm rods) were harvested after \~10 days.

Data were collected at Advanced Photon Source beamline 24ID-C. Crystals were located by grid scanning with a 70 μm beam at 70% transmission followed by focused grid scanning with a 10 μm beam at 100% transmission. Data wedges were typically collected from −30° to +30° in 0.2° increments using a 10 μm beam at 100% transmission. Two wedges from two crystals (G45R), 23 wedges from \~15 crystals (G223W with Mn^2+^), or 39 wedges from \~20 crystals (G223W apo) were independently indexed and integrated then combined during scaling using HKL2000 ([@bib44]) to obtain complete datasets. Structures were determined using software provided by SBGrid ([@bib41]). Initial phases were obtained by molecular replacement in PHASER ([@bib39]) using our first DraNramp structure (PDB: 5KTE) as a search model for G45R and an in-progress G45R model for G223W. Model building and refinement were iterated in Coot ([@bib20]) and PHENIX ([@bib3]), respectively. For all structures, positional and B-factor refinement with TLS restraints were used throughout, with torsion angle and NCS restraints for G45R, and secondary structure restraints for the Patch mutant. G45R contains two protein molecules in the asymmetric unit---chain A with residues 45--167 and 174--436 and chain B with residues 44--168 and 175--436 (RMSD 0.86 Å over 2899 atoms, 0.50 Å over all 386 Cαs)---and six fully or partly modeled monoolein molecules. Chain A was used for figures and analyses. The G223W Mn^2+^-bound structure includes residues 39--436, ten full or partial monooleins, one spermidine molecule, and two Mn^2+^ ions---one in the metal-binding site, one at a crystal-packing interface. The G223W apo structure includes residues 39--436 and six full or partial monooleins. The two G223W structures align with RMSD 1.41 Å over 3012 atoms, 1.08 Å over all 398 Cαs). The electron density for each TM is shown in [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"} for G45R and [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"} for G223W with Mn^2+^, while [Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"} shows the metal-binding site for both the Mn^2+^-bound and apo G223W structures. The inward-open Patch mutant structure was updated to correct the position of intracellular loop 10--11 and the registry of TM11, and extend the N-termini of TMs 5, 7 and 9, the C-terminus of TM7, and extracellular loop 7--8, and improve the geometry of the Fab. The new model comprises residues 43--165, 170--236, 256--341, 351--436 of DraNramp, 1--129 and 132--213, and 1--213 of the Fab heavy and light chains, respectively, and three Os^3+^ ions.

In vivo metal transport assays {#s4-4}
------------------------------

Metal uptake assays in *E. coli* were performed as described previously ([@bib8]). For each biological replicate reported in figure legends, a separate culture of transformed *E. coli* was grown and induced to express the exogenous Nramp construct.

Purification of DraNramp constructs for proteoliposome assays {#s4-5}
-------------------------------------------------------------

DraNramp constructs were cloned, expressed, and purified as described above, with the following changes: protein was purified from cell pellets in a single day, and washed/eluted from nickel beads in buffers with 0.03% DDM. Protein was concentrated to 2.5 mL and buffer-exchanged into 100 mM NaCl, 10 mM HEPES pH 7.5, 0.1% n-Decyl-β-D-Maltopyranoside (DM) on a PD10 desalting column. Protein concentrations were normalized to 1.2 mg/mL and aliquots were flash frozen in liquid nitrogen. Single-cysteine constructs A53C and A61C were purified in the presence of 1 mM DTT.

Proteoliposome preparation {#s4-6}
--------------------------

Adjusting the lipid composition ([@bib19]) of a previous protocol ([@bib8]; [@bib60]), 75% w/w 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) was mixed with 25% w/w 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) in chloroform (Avanti Polar Lipids), and then dried under nitrogen in a warm water bath, re-dissolved in pentane, and dried again. Lipids were resuspended at 20 mg/mL in 5 mM DM in KCl + NaCl/MOPS buffer (typically \~90 mM KCl, 30 mM NaCl, 0.5 mM or 10 mM MOPS pH 7). Protein was added at a 1:400 w/w ratio to lipid, and the mixture dialyzed at 4°C to remove the detergent in 10 kDa molecular weight cutoff dialysis cassettes against KCl + NaCl/MOPS buffer with 0.2 mM EDTA for 1 day, then with 0.1 mM EDTA for 1--3 days, then overnight at room temperature (RT) against KCl + NaCl/MOPS buffer. For A53C and A61C, 1 mM, and 0.5 mM DTT was included in the first two dialysis steps. Fluorescent dye (either 1:49 v/v 5 mM Fura-2 pentapotassium salt or 1:66 v/v 10 mM 2\',7\'-bis(carboxyethyl)−5(6)-Carboxyfluorescein (BCECF) in dimethyl sulfoxide) was incorporated into proteoliposomes permeabilized by three freeze-thaw cycles in dry ice-ethanol and RT water baths (and sometimes stored at −80°C after the third freeze). Proteoliposomes were extruded through a 400 nM filter to create uniform-sized vesicles, buffer-exchanged 1--2 times on a PD10 desalting column pre-equilibrated with NaCl/ or KCl/10 mM MOPS pH 7 buffer. Peak proteoliposome-containing fractions were pooled to remove unincorporated dye.

Proteoliposome transport assays and data analysis {#s4-7}
-------------------------------------------------

Proteoliposomes loaded with either 100 μM Fura-2 or 150 μM BCECF were diluted into buffer containing appropriate \[KCl\] to establish the desired membrane potential ([@bib22]; [@bib61]) and aliquoted into 96 well black clear-bottom plates. Following baseline fluorescence measurement, 5X metal (750 μM final concentration unless otherwise noted) and valinomycin (100 nM final concentration) were added. Stocks of 100 mM CdCl~2~, MnCl~2~, and Co(NO~3~)~2~, as well as appropriate serial dilutions in water for concentration range experiments, were freshly diluted into appropriate NaCl or KCl buffer with pre-added valinomycin. To pre-modify cysteines (A53C or A61C when applicable), liposomes were diluted into buffer (120 mM NaCl, 10 mM MOPS pH 7) containing 3 mM MTSET, 3 mM MTSEA, or 4 mM NEM, and incubated at least 30 min at RT before beginning transport assays. Metal transport was monitored by measuring Fura-2 fluorescence at λ~ex~ = 340 and 380 nm, at λ~em~ = 510 nm. Proton transport was monitored by measuring BCECF fluorescence at λ~ex~ = 450 and 490 nm, at λ~em~ = 535 nm. To calculate concentrations of imported metal, the Fura-2 340/380 ratio and an experimentally determined K~D~ value ([@bib28]) was used for Cd^2+^ as described previously ([@bib8]). For Mn^2+^ and Co^2+^, the fraction of Fura-2 340 and 380 fluorescence quenched, normalized to maximum observed quenching, was used to estimate imported metal. For proton uptake, the BCECF 450/490 ratio was used to calculate internal pH, which along with the known total internal buffer (0.5 mM) and dye (150 μM) concentration was used to calculate net proton import via the Henderson-Hasselbalch equation. The effect of divalent cations on BCECF fluorescence under analogous conditions to the liposome assay was tested ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), which showed that Mn^2+^, Co^2+^, Zn^2+^, Cd^2+^, Ca^2+^ had no effect while Fe^2+^ had a slight effect but of a much smaller magnitude than adding an equivalent concentration of H^+^ or OH^-^. Initial rates were calculated in Excel and Michaelis-Menten parameters were fit using MATLAB. For each technical replicate reported in figure legends, a separate aliquot of dye-loaded proteoliposomes was diluted into the appropriate outside buffer, including cysteine modifiers if applicable, then fluorescence time course data were collected before and after the addition of valinomycin, metal substrate, and/or ionomycin.

Thrombin cleavage assay {#s4-8}
-----------------------

DraNramp proteoliposomes with a 1:200 w/w ratio of protein to lipid were formed as described above, in 90 mM KCl, 30 mM NaCl, 10 mM MOPS pH 7, and extruded 19 times. Additional purified DraNramp was diluted to 0.1 mg/ml in the same buffer with 0.1% DM. A 1/16 vol of 250 mM Tris pH 8.25 was added to the proteoliposomes or detergent-solubilized protein to adjust the pH to 8.0 for optimal thrombin activity. After removing a 0 min aliquot, thrombin from human plasma (EMD Biosciences) was added to final concentrations of 2.5 or 10 U/mL, and timed aliquots were removed and quenched by adding excess PMSF (\~3 mM) and sample buffer. Samples were run on SDS-PAGE and stained with Coomassie. Band intensities corresponding to the full-length (48.2 kDa) and thrombin-cleaved (42.9 kDa) proteins were calculated using ImageJ64, and the fraction of the protein in the lower band (corrected for the molecular weights) was determined.

Cysteine accessibility measurements {#s4-9}
-----------------------------------

Cells grown as for the uptake assay were washed once in labeling buffer (100 mM Tris pH 7.0, 60 mM NaCl, 10 mM KCl, 0.5 mM MgCl~2~, 0.75 mM CaCl~2~), resuspended at OD~600~ = 2, and aliquoted 100 μL per well in a 96-well plate. A 1:1 NEM dilution series was prepared in labeling buffer at 8 mM; 100 μL of the appropriate 2X NEM solution was added to each well and incubated 15 min at RT. L-cysteine (10 μL of 200 mM) was added to quench NEM. Cells were washed twice in labeling buffer, pelleted, resuspended in 30 μL lysis and denaturing buffer (6 M urea, 0.1% SDS, 100 mM Tris pH 7) with 0.5 mM DTT and incubated 1 hr at 37°C. The lysate (10 μL) was mixed with 3.5 μL of 6 mM 5K-PEG maleimide (Creative PEGWORKS) in lysis and denaturing buffer, incubated 1 hr at 37°C, and the reaction terminated by adding sample buffer with β-mercaptoethanol. Protein was detected via SDS-PAGE and western blotting using an Alexa 647-conjugated anti-His-tag antibody (QIAGEN) and a Typhoon Imager (GE Healthcare). ImageJ64 was used to determine the % modification as described ([@bib9]). For each biological replicate reported in figure legends, a separate culture of transformed *E. coli* was grown and induced to express the exogenous Nramp construct.

Sequence alignments {#s4-10}
-------------------

An alignment of 9289 Nramp sequences was obtained from a HMMER ([@bib21]) search using the DraNramp sequence with an E-value of 1, filtered for sequences with just one domain, then filtered for sequences 400--600 residues long. Incomplete sequences and sequences lacking the canonical Nramp TM1 'DPGN' and TM6 'MPH' motifs were removed, yielding 6878 sequences. A seed of 92 diverse sequences were aligned using MUSCLE ([@bib17]), then HMMER was used with a gap threshold of 0.99 to create the final alignment ([Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}).

Structural comparisons and analyses {#s4-11}
-----------------------------------

Per-residue Cα RMSD values were calculated using the ColorByRMSD PyMOL script, and whole-structure Cα RMSD values using the PyMOL align command with cycles = 0. To generate the distance difference matrices, the pairwise distances between all Cα atoms were calculated for each structure (inward, inward-occluded, and outward). Then, for each combination of two conformations, a distance difference matrix was calculated by taking the difference between the distance matrices corresponding to each conformation. These distance-difference values were then averaged for each pair of TM helices (after dividing TMs 1, 6, and 10 into 'a' and 'b' segments) using an RMSD-like calculation to obtain a 14×14 matrix for each pair of conformations. The python code used to perform these calculations and generate the resulting plots is available at GitHub: <https://github.com/GaudetLab/coarse-grained-DDMP> (copy archived at <https://github.com/elifesciences-publications/coarse-grained-DDMP>). pK~a~ values were calculated using PROPKA ([@bib16]) with CHARMM forcefields.

Data availability {#s4-12}
-----------------

The accession number for the DraNramp crystal structures reported in this paper are G45R inward-occluded, PDB ID: 6C3I; G223W ∆N34 outward-open with Mn^2+^, PDB ID: 6BU5; G223W ∆N34 outward-open apo, PDB ID: 6D91; revised inward open, PDB ID: 6D9W. The unprocessed diffraction images were deposited in the SBGrid Data Bank (<https://data.sbgrid.org/>) with SBGDB ID: 567 (G45R); 564 and 576 (G223W ∆N34 Mn^2+^-bound and apo respectively); and 332, 333, and 334 (inward-open). The raw biochemical data that support the findings of this study are available from the corresponding author upon reasonable request.
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Data availability {#s7}
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Source data for the Nramp sequence alignment have been provided as Figure 2-source data 1. Structural coordinates and structure factors for each crystal structure have been deposited in the PDB under accession codes 6D9W, 6C3I, 6BU5, and 6D91. The unprocessed X-ray diffraction images have been deposited in the SBGrid Data Bank under accession codes 332, 333, 334, 567, 564, and 576. All other data generated or analyzed in this study are included in the manuscript.

The following datasets were generated:

ZimanyiCMBozziATGaudetR2018Crystal structure of the Deinococcus radiodurans Nramp/MntH divalent transition metal transporter G45R mutant in an inward occluded stateProtein Data Bank6C3I

BozziATZimanyiCMNicoludisJMGaudetR2017Crystal structure of the Deinococcus radiodurans Nramp/MntH divalent transition metal transporter in the outward-open, manganese-bound conformationProtein Data Bank6BU5

BozziATZimanyiCMNicoludisJMGaudetR2018Crystal structure of the Deinococcus radiodurans Nramp/MntH divalent transition metal transporter in the outward-open, apo conformationProtein Data Bank6D91

GaudetRBaneLBWeihofenWASingharoyAZimanyiCMBozziAT2018Crystal structure of Deinococcus radiodurans MntH, an Nramp-family transition metal transporter, in the inward-open apo stateProtein Data Bank6D9W

ZimanyiCMBozziATGaudetR2016X-Ray Diffraction data from Deinococcus radiodurans Nramp/MntH divalent transition metal transporter mutant G45R, source of 6C3I structureSBGrid Data Bank10.15785/SBGRID/567

BozziATZimanyiCMNicoludisJMGaudetR2017X-Ray Diffraction data from Deinococcus radiodurans Nramp/MntH divalent transition metal transporter in the outward-open, manganese-bound state, source of 6BU5 structureSBGrid Data Bank10.15785/SBGRID/564

BozziATZimanyiCMNicoludisJMGaudetR2017X-Ray Diffraction data from Deinococcus radiodurans Nramp/MntH divalent transition metal transporter mutant G223W, apo, source of 6D91 structureSBGrid Data Bank10.15785/SBGRID/576

The following previously published datasets were used:

BaneLB2010X-Ray Diffraction data from Deinococcus radiodurans MntH in complex with Fab, source of 5KTE structureSBGrid Data Bank10.15785/SBGRID/332

BaneLBWeihofenWAGaudetR2010X-Ray Diffraction data from Deinococcus radiodurans MntH in complex with Fab, source of 5KTE structureSBGrid Data Bank10.15785/SBGRID/333

BaneLBWeihofenWAGaudetR2011X-Ray Diffraction data from Deinococcus radiodurans MntH in complex with Fab, source of 5KTE structureSBGrid Data Bank10.15785/SBGRID/334
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Structures in multiple conformations reveal distinct transition metal and proton pathways in an Nramp transporter\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by José Faraldo-Gómez as Reviewing Editor and Michael Marletta as the Senior Editor. All reviewers have agreed to reveal their identity: Ming Zhou (Reviewer \#1); Dirk Slotboom (Reviewer \#2); Gary Rudnick (Reviewer \#3).

The reviewers have discussed the reviews with one another and with the Reviewing Editor, who has drafted this decision to help you prepare a revised submission.

The reviewers have no major concerns with your structural work, which they see as an important advancement in the field, and in this regard they recommend only minor changes to clarify the presentation and discussion of the data, as noted below. The reviewers are also very impressed by the effort invested in the functional characterization of the transporter. However, they also find that the current interpretation of this data in mechanistic terms is less than compelling, and that a clear conclusion would require additional functional assays and some key controls, which are also enumerated below. Should you be unable to provide this new data, we ask that you thoroughly reformulate the discussion of your results, so as to more accurately convey the significance of the existing data, and the questions that remain unanswered; in this case, the conclusions, Abstract and title ought to be amended accordingly.

A central concern is whether the observation of uncoupled proton fluxes under specific experimental conditions and only for the outward-facing form of the transporter is actually informing on the nature of the mechanism of the transporter as it carries out its presumed biological function, i.e. symport. While your data appears to enable you to delineate the pathway for passive proton leak, the claim that this process coincides with that of proton binding and release in the context of active proton-coupled metal uptake does not seem to be directly supported by the data presented. That the measured proton uptake increases in the presence of a transportable substrate does not fully resolve this question, as it is unclear whether this increase is due to more of the uncoupled proton flux, to substrate-stimulated flux, to coupled proton-substrate uptake, or to some combination of these processes. Indeed, there are examples of ion fluxes through transporters that are stimulated by substrate binding or transport (EAATs and biogenic amine NSS transporters), where those fluxes are mechanistically independent from substrate transport.

A related key concern pertains to the molecular mechanism you outline in Figure 7C, in that it does not appear to explain symport, except in very specific conditions. In this model, 1:1 symport appears to require (a) that protons bind to the outward-facing transporter (only) from the outside, even though you also propose that a pathway exists to the intracellular side; (b) that protons are ejected upon metal binding (only) to the inside, even though the protein is outward-facing; and (c) that after metal release into the interior, the apo outward-facing transporter does not (ever) mediate uncoupled outward proton flux, even though this flux occurs in metal-free conditions. In this model, therefore, the directionality of the symport reaction appears to require the continued presence of inward electrochemical gradients for both metal and proton (or that the intrinsic microscopic reversibility of each of these steps is violated). By definition, however, a symport mechanism must explain co-transport even when one of the transported substrates is subject to an opposing driving force, or none at all.

Essential revisions

1\) In order to preserve the current claims in regard to the mechanism of proton-driven symport, and its relationship to the observation of uncoupled fluxes, it would be essential to (a) demonstrate the actual symport activity of the transporter; and (b) clarify how much (if any) of the measured proton flux is actually coupled to active metal transport. Direct information on the flux stoichiometry (how many protons are transported for each transported metal ion) and the reversal potential for the proton fluxes would help to support to clarify these questions. Demonstrating that a gradient of Mn^2+^ could drive protons across the membrane would be a powerful argument in favor of symport, provided there were no other driving force for proton influx. In all the experiments presented, a K^+^ diffusion potential creates an electrical driving force for proton influx. If this potential was neutralized or reversed, would protons be driven into or out of the proteoliposomes by a transmembrane gradient of metal ion substrate? Our view is that in the absence of these key experiments, it would be premature to make any statements about the mechanism that (hypothetically) couples the translocation of protons and metals through the membrane, and how it might be similar or different from that of proton leak.

2\) The interpretation of the experiments described in subsection "DraNramp proton transport does not require large conformational change", in which membrane permeable and impermeable reagents were used to modify cysteines, relies heavily on the assumption that the protein reconstitutes in both orientations with similar probability. This assumption must be tested experimentally. Some proteins, like LacY, have a strong preference for insertion in one orientation. Without direct experimental evidence in this regard, not based on transport measurements, alternative interpretations should be put forward that consider the case that the protein has a strong preference for insertion in one orientation, like other transporters e.g. LacY.

3\) Finally, the authors must elaborate on what is the expected response of the proton indicator to the presence of divalent cations, ideally with a control experiment or a reference to existing data in this regard.

10.7554/eLife.41124.044

Author response

> The reviewers have no major concerns with your structural work, which they see as an important advancement in the field, and in this regard they recommend only minor changes to clarify the presentation and discussion of the data, as noted below. The reviewers are also very impressed by the effort invested in the functional characterization of the transporter. However, they also find that the current interpretation of this data in mechanistic terms is less than compelling, and that a clear conclusion would require additional functional assays and some key controls, which are also enumerated below. Should you be unable to provide this new data, we ask that you thoroughly reformulate the discussion of your results, so as to more accurately convey the significance of the existing data, and the questions that remain unanswered; in this case, the conclusions, Abstract and title ought to be amended accordingly.
>
> A central concern is whether the observation of uncoupled proton fluxes under specific experimental conditions and only for the outward-facing form of the transporter is actually informing on the nature of the mechanism of the transporter as it carries out its presumed biological function, i.e. symport. While your data appears to enable you to delineate the pathway for passive proton leak, the claim that this process coincides with that of proton binding and release in the context of active proton-coupled metal uptake does not seem to be directly supported by the data presented. That the measured proton uptake increases in the presence of a transportable substrate does not fully resolve this question, as it is unclear whether this increase is due to more of the uncoupled proton flux, to substrate-stimulated flux, to coupled proton-substrate uptake, or to some combination of these processes. Indeed, there are examples of ion fluxes through transporters that are stimulated by substrate binding or transport (EAATs and biogenic amine NSS transporters), where those fluxes are mechanistically independent from substrate transport.
>
> A related key concern pertains to the molecular mechanism you outline in Figure 7C, in that it does not appear to explain symport, except in very specific conditions. In this model, 1:1 symport appears to require (a) that protons bind to the outward-facing transporter (only) from the outside, even though you also propose that a pathway exists to the intracellular side; (b) that protons are ejected upon metal binding (only) to the inside, even though the protein is outward-facing; and (c) that after metal release into the interior, the apo outward-facing transporter does not (ever) mediate uncoupled outward proton flux, even though this flux occurs in metal-free conditions. In this model, therefore, the directionality of the symport reaction appears to require the continued presence of inward electrochemical gradients for both metal and proton (or that the intrinsic microscopic reversibility of each of these steps is violated). By definition, however, a symport mechanism must explain co-transport even when one of the transported substrates is subject to an opposing driving force, or none at all.

We are grateful for the thorough and insightful reviews. This revised manuscript addresses the comments in the decision letter, as detailed on the following pages below. We believe our revisions have significantly improved the quality of the manuscript.

We have edited the model we present in Figure 7C to remove the word "symport" which we agree we have not conclusively demonstrated for DraNramp (or any Nramp homolog), with "metal and proton transport," to describe the observed metal transport and metal-stimulated proton transport we measure in Figure 5. We also now stress that this model is meant to show the dominant activity of the protein in its physiological context in which prevailing pH gradients and voltage would favor outward-to-inward transport. In the figure legend we now call this the DraNramp "model under prevailing physiological conditions (negative inside membrane potential, acidic-outside pH gradient)" and in the figure we indicate the presence of these favorable electrochemical gradients.

> Essential revisions
>
> 1\) In order to preserve the current claims in regard to the mechanism of proton-driven symport, and its relationship to the observation of uncoupled fluxes, it would be essential to (a) demonstrate the actual symport activity of the transporter; and (b) clarify how much (if any) of the measured proton flux is actually coupled to active metal transport. Direct information on the flux stoichiometry (how many protons are transported for each transported metal ion) and the reversal potential for the proton fluxes would help to support to clarify these questions.

Our aim in this paper is to present the structural basis for DraNramp proton and metal transport without delving in-depth into the coupling mechanism. While we can now readily perform kinetic analyses of metal and proton fluxes, we concur with the reviewers that a formal demonstration of coupled symport would require experiments assessing transport under different thermodynamic equilibria conditions, which will require significant modification and optimization of our in vitro system and are beyond the scope of this study.

We therefore carefully modified our manuscript to make clear that we have not conclusively demonstrated a symport mechanism in DraNramp, and to more generally stress the limits of current knowledge. These changes include minimizing the use of terms such as "symport", "co-transport", and "coupling". We also added a statement in the Introduction explaining that thermodynamic coupling has not yet been demonstrated in Nramps, because to our knowledge no study in the literature has met this standard with any Nramp transporter. Nevertheless, many Nramp papers starting with the original characterization (Gunshin et al., 1997) have included significant speculation and discussion of a potential symport mechanism based on data similar to what we present. We thus consider it important and appropriate to discuss the possibility of symport in the current work, while remaining open to other possibilities regarding the transport mechanism and modified the discussion to make explicit these possibilities.

> Demonstrating that a gradient of Mn^2+^ could drive protons across the membrane would be a powerful argument in favor of symport, provided there were no other driving force for proton influx. In all the experiments presented, a K^+^ diffusion potential creates an electrical driving force for proton influx. If this potential was neutralized or reversed, would protons be driven into or out of the proteoliposomes by a transmembrane gradient of metal ion substrate? Our view is that in the absence of these key experiments, it would be premature to make any statements about the mechanism that (hypothetically) couples the translocation of protons and metals through the membrane, and how it might be similar or different from that of proton leak.

As we showed in a forthcoming manuscript (Bozzi et al., 2018, currently deposited on bioRxiv), Mn^2+^ transport is highly dependent on voltage under our currently established experimental conditions, such that the WT protein does not transport metal in the absence of a favorable ΔΨ, which unfortunately precludes us from testing whether a metal gradient could drive proton influx at ΔΨ = 0 or ΔΨ \> 0. Therefore, while we are very much interested in determining whether there is indeed thermodynamic coupling between proton and metal transport, it will require exploring and optimizing our experimental system beyond the scope of this current structure-focused manuscript.

The mutagenesis data in the forthcoming manuscript mentioned above (Figure 6C and Figure 6---figure supplement 2) showed that neutralizing the same four residues that eliminated voltage-driven H^+^ uniport (D56, D131, E134, and H232) also eliminated (D56, D131, H232) or drastically-reduced (E134) metal-stimulated H^+^ transport. These results support our assertion that the metal-stimulated H^+^ transport likely follows the same transport pathway as the H^+^ uniport. We therefore now state in the discussion: "For metal-stimulated proton transport, Mn^2+^ binding likely stimulates proton transfer into the same salt-bridge network, perhaps by directly ejecting a proton from D56 in the metal-binding site. Indeed, in a separate study we show that neutralizing mutations to the same four residues that eliminated H^+^ uniport (Figure 6E) also eliminated (D56, D131, H232) or severely-reduced (E134) H^+^ fluxes in the presence of added Mn^2+^, with mutants to D131, E134, and H232 retaining significant metal-transport ability despite a lack of proton transport (Bozzi et al., bioRxiv, 2018). However, the precise order of events for proton-metal transport, including whether it is indeed a co-transport mechanism, remains undetermined at this time, and additional transport mechanisms are possible."

> 2\) The interpretation of the experiments described in subsection "DraNramp proton transport does not require large conformational change", in which membrane permeable and impermeable reagents were used to modify cysteines, relies heavily on the assumption that the protein reconstitutes in both orientations with similar probability. This assumption must be tested experimentally. Some proteins, like LacY, have a strong preference for insertion in one orientation. Without direct experimental evidence in this regard, not based on transport measurements, alternative interpretations should be put forward that consider the case that the protein has a strong preference for insertion in one orientation, like other transporters e.g. LacY.

We agree that determining the liposome orientation profile of DraNramp is necessary to fully interpret our liposome assay data. We therefore adapted an assay used in other transporters (Tsai et al., 2012 and Tsai et al., 2013) that uses thrombin to cleave DraNramp at a naturally-occurring cleavage site in the non-conserved, disordered N-terminal region before TM1a. In a new figure (Figure 5---figure supplement 2) we show that while thrombin fully cleaves DraNramp in detergent, only \~50% of liposome-reconstituted DraNramp is cleaved by added external thrombin. This result indicates that \~50% of the protein reconstitutes in an inside-out orientation with an exposed N-terminal, while the remaining \~50% reconstitutes in an outside-out orientation with its N-terminal enclosed in the proteoliposome and thus protected from external thrombin. We believe this experiment convincingly demonstrates that DraNramp indeed orients randomly in our proteoliposome production protocol.

We added the relevant information to the Materials and methods section and describe these results at the end of the "DraNramp proton transport does not require large conformational change" section:

"To confirm that a mix of inside-out and outside-out transporters were indeed present in proteoliposomes, we assessed the susceptibility of DraNramp to thrombin cleavage at a naturally-occurring site (Gallwitz et al., 2012) in the protein's non-conserved, disordered N-terminal region (Figure 5---figure supplement 2A-C). While thrombin fully cleaved DraNramp in detergent, in proteoliposomes the cleaved protein population plateaued at \~50% (Figure 5---figure supplement 2D-F). This cleaved portion likely corresponds to inside-out oriented protein with an exposed N-terminal region, with the remaining \~50% of protein therefore outside-out oriented with the N-terminus inside the liposome and thus protected from thrombin cleavage (Tsai et al., 2012; Tsai et al., 2013)."

> 3\) Finally, the authors must elaborate on what is the expected response of the proton indicator to the presence of divalent cations, ideally with a control experiment or a reference to existing data in this regard.

We performed the requested control experiment, included as the new Figure 5---figure supplement 3. Mn^2+^, Co^2+^, Zn^2+^, Cd^2+^, and Ca^2+^ have no significant effect on BCECF fluorescence, while Fe^2+^ had a slight effect, only \~12% in magnitude than the equivalent H^+^ concentration. Thus, the presence of divalents should not be a concern in all the assays presented in this manuscript, and this control experiment supports our conclusions based on these data.
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